Protein phosphorylation in neurodegeneration: friend or foe?
about
Phosphatases of α-synuclein, LRRK2, and tau: important players in the phosphorylation-dependent pathology of ParkinsonismNuclear Tau and Its Potential Role in Alzheimer's DiseaseThe Role of Oxidative Damage in the Pathogenesis and Progression of Alzheimer's Disease and Vascular DementiaMilk--A Nutrient System of Mammalian Evolution Promoting mTORC1-Dependent TranslationC-Terminal Tyrosine Residue Modifications Modulate the Protective Phosphorylation of Serine 129 of α-Synuclein in a Yeast Model of Parkinson's Disease.Protein misfolding and aggregation in Alzheimer's disease and type 2 diabetes mellitusDefying c-Abl signaling circuits through small allosteric compounds.Nigral proteasome inhibition in mice leads to motor and non-motor deficits and increased expression of Ser129 phosphorylated α-synucleinNeuroprotective Functions for the Histone Deacetylase SIRT6Phosphoproteomic profiling of selenate-treated Alzheimer's disease model cells.The Interplay between Alpha-Synuclein Clearance and SpreadingInteraction between Neuromelanin and Alpha-Synuclein in Parkinson's Disease.An Effective Method to Identify Shared Pathways and Common Factors among Neurodegenerative DiseasesEnteric nervous system α-synuclein immunoreactivity in idiopathic REM sleep behavior disorder.Intracellular repair of oxidation-damaged α-synuclein fails to target C-terminal modification sitesThe incubation period of Alzheimer's disease and the timing of tau versus amyloid misfolding and spreading within the brain.Poststroke Induction of α-Synuclein Mediates Ischemic Brain Damage.Loss of Tau protein affects the structure, transcription and repair of neuronal pericentromeric heterochromatinAttenuation of synaptic toxicity and MARK4/PAR1-mediated Tau phosphorylation by methylene blue for Alzheimer's disease treatment.Selective suppression of the α isoform of p38 MAPK rescues late-stage tau pathology.Phosphoproteome Discovery in Human Biological Fluids.Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice.Posttranslational Modifications and Clearing of α-Synuclein Aggregates in YeastBattling Alzheimer's Disease: Targeting SUMOylation-Mediated Pathways.Sorting out release, uptake and processing of alpha-synuclein during prion-like spread of pathology.Review: Spreading the word: precise animal models and validated methods are vital when evaluating prion-like behaviour of alpha-synuclein.Implication of Alpha-Synuclein Phosphorylation at S129 in Synucleinopathies: What Have We Learned in the Last Decade?The Proteasome Inhibition Model of Parkinson's Disease.Regulatory region genetic variation is associated with FYN expression in Alzheimer's disease.CK2-An Emerging Target for Neurological and Psychiatric Disorders.Regulation of motor proteins, axonal transport deficits and adult-onset neurodegenerative diseases.Phosphorylation Interferes with Maturation of Amyloid-β Fibrillar Structure in the N Terminus.Cerebrospinal fluid biomarkers and clinical features in leucine-rich repeat kinase 2 (LRRK2) mutation carriers.Phosphorylation modifies the molecular stability of β-amyloid deposits.Isoelectric point-based fractionation by HiRIEF coupled to LC-MS allows for in-depth quantitative analysis of the phosphoproteome.Membrane Binding of Parkinson's Protein α-Synuclein: Effect of Phosphorylation at Positions 87 and 129 by the S to D Mutation Approach.Critical Roles of Dual-Specificity Phosphatases in Neuronal Proteostasis and Neurological Diseases.The effect of Scutellaria baicalensis stem-leaf flavonoids on spatial learning and memory in chronic cerebral ischemia-induced vascular dementia of rats.Regulation and targeting of enzymes mediating Parkinson's disease pathogenesis: focus on Parkinson's disease kinases, GTPases, and ATPasesPhosphorylation of the FUS low-complexity domain disrupts phase separation, aggregation, and toxicity.
P2860
Q21131229-6232BA4F-65A1-46B5-BFDC-AC2ECC5BF6C3Q26769950-41BD725C-9F26-4B10-9353-B2C2B18D8A86Q26795415-0BCC3130-2DAA-4722-9E2F-C1FC1311879FQ26801523-FB01FB36-FD4A-4ECC-B61F-A5CF7EE2AD41Q27931024-0D2F2C2A-48CB-439E-81E7-70175A74323AQ28397425-C5597E3F-894B-4D21-B5DB-090EB7DDE77AQ30009269-FB8CD36E-F375-4405-A44F-B2B99E722B79Q30633819-1B809B93-543C-4FE4-B1B0-EB300428EC41Q34554358-D3089793-FDE8-463F-9D47-A6B50361955BQ34653771-80DCF083-3059-42FF-8B23-32AE3D2A2F4BQ35833984-9AB80446-1455-4AF8-9978-DC5453030BB7Q35834043-EFEFB8AF-DACF-4C84-8CFE-C05C2E5EFE66Q35843631-14D26BCF-2F8D-42CF-B4F7-6F516F1DDDBCQ36300054-5A5002AF-31FD-46C6-B4C0-14122D92AB52Q36534162-D35DD70B-672C-4201-80AB-DD23B55FDD1EQ36762790-8617B56A-34F6-454A-9682-22B7315A2EBEQ37196992-C54E0590-7A60-4AEF-9E9A-ED7BE773FA77Q37239971-72DF7463-5567-4229-8DBA-AF66B7EAD4C2Q37314665-F5764BBE-3075-4CF2-8E5D-9D17EC8FDDD1Q37504904-09126009-A572-4F5B-9AB6-82A1FD71A914Q37603413-73346BB7-CC37-4AD2-947D-9DBE755F81A2Q37701053-684DE398-ED53-4F67-A1AA-877535E3836AQ38444052-0214D768-140B-479E-9D9B-162F6623BC53Q38557970-CB683B47-7060-4F73-B567-59B78D7594F1Q38652662-DD377A20-B386-4B8B-ACF4-AA56681530B1Q38669105-E8F437AF-9A54-4FF8-B023-65D93D47CBE5Q38785080-87F7545B-50A2-47C9-A027-03E313A3F5E1Q38996038-76E88B4B-D9B9-4601-B54F-687DC85ECD71Q39052950-6531584F-F1F2-4740-BC2A-D53A06791417Q39076762-1DEAD420-68DD-42BD-933D-8DD39B658621Q39243689-EEDCF84A-747B-43D0-9E58-6F310E1F5E42Q39716461-C0397BBE-4633-48DF-B7C3-589AF1135C88Q39866469-91AAB5D3-5AC7-4E5C-ABC3-9F4A9E79A0CCQ40249589-4979D9ED-FE0C-4805-AFD2-8D532DFD8BD9Q40971844-C3C0336F-F6C9-4154-84C6-F989A961BCB4Q41539970-64183CCF-92B8-49D5-B7EC-6520CC282BF9Q41660620-B61B6E36-3AD9-486F-87A3-468B241D1017Q41884186-87C0A62C-EB01-4E14-BF29-B48D27EB2CFCQ42051042-4F7CEF81-E36F-4010-981D-BC6E305E3EAAQ42378053-55936BD8-58BC-464C-A478-88E9213FD51C
P2860
Protein phosphorylation in neurodegeneration: friend or foe?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Protein phosphorylation in neurodegeneration: friend or foe?
@en
type
label
Protein phosphorylation in neurodegeneration: friend or foe?
@en
prefLabel
Protein phosphorylation in neurodegeneration: friend or foe?
@en
P2860
P356
P1476
Protein phosphorylation in neurodegeneration: friend or foe?
@en
P2093
Katrin Eckermann
P2860
P356
10.3389/FNMOL.2014.00042
P577
2014-05-13T00:00:00Z